Monoclonal Antibodies in the News
- Risk of Severe Arboviral Disease in Patients Receiving B Cell-Depleting or Modulating Medications - Centers for Disease Control and Prevention | CDC (.gov)
- CDC Warns of Severe Arboviral Disease With B-Cell Drugs - MedPage Today
- Infinimmune raises USD 75m to bring IL-22 antibody into clinic - AllSci
- Sanofi Pauses Phase 2 Trial of Monoclonal Antibody SAR445399 in Chronic Lung Disease - BioPharm International
- Infinimmune Raises $75 Million Series A Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory Disease - Business Wire
©
2026
MAb Technologies | monoclonal antibodies to transporter proteins
Website by 3by400, North Georgia web design team using Joomla!
Website by 3by400, North Georgia web design team using Joomla!